Paper Details

  1. Home
  2. Paper Details

Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis.

Author: AdenisJ P, ColinJ, MaletF, Saint-BlancatP, VerinP

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Ciprofloxacin ophthalmic solution (0.3%) was effective and well tolerated for the treatment of bacterial conjunctivitis and blepharitis. Clinical cure rates were higher with ciprofloxacin than rifamycin (53% vs 23%), although bacteriological eradication rates were similar.
Paper Details　
Original Abstract of the Article :
The efficacy and safety of ciprofloxacin (0.3%) ophthalmic solution and rifamycin (1%) ophthalmic solution for the treatment of bacterial conjunctivitis and blepharitis was compared in this randomized, double-masked, parallel-group study. Forty-one patients, 19 on ciprofloxacin and 22 on rifamycin, ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/112067219500500203

データ提供：米国国立医学図書館（NLM）

Conquering Conjunctivitis and Blepharitis: A Battle of Eye Drops

Conjunctivitis and blepharitis are common eye infections that can be quite irritating. This study compared the effectiveness of two different eye drops: ciprofloxacin and rifamycin. The researchers wanted to see which eye drop worked better for treating these infections. They found that both eye drops were effective in improving symptoms, but ciprofloxacin appeared to be slightly better at completely clearing the infection.

Ciprofloxacin: A Potential Winner in the Eye Drop Race

This study suggests that ciprofloxacin might be a more effective treatment option for bacterial conjunctivitis and blepharitis compared to rifamycin. This is like a fierce competition in the desert, where ciprofloxacin emerges as a potential victor.

Treating Eye Infections: Don’t Let the Sand Get in Your Eyes

If you have an eye infection, it’s important to see a doctor to get the right treatment. Don’t try to self-treat, as this could lead to complications.

Dr.Camel's Conclusion

Ciprofloxacin appears to be a promising treatment option for bacterial conjunctivitis and blepharitis. But remember, every patient is different, and what works for one person may not work for another. Always consult with a doctor for proper diagnosis and treatment.

Date :
  1. Date Completed 1995-11-07
  2. Date Revised 2022-10-07
Further Info :

Pubmed ID

7549447

DOI: Digital Object Identifier

10.1177/112067219500500203

Related Literature

Article Analysis
・Effects of ciprofloxacin ophthalmic
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.